EPISODE · Feb 8, 2018 · 9 MIN
Can DAA therapy for HCV reactivate HBV in coinfected patients?
from Listen to The Lancet Gastroenterology & Hepatology · host The Lancet
In this Lancet Gastroenterology & Hepatology podcast, Johannes Vermehren discusses the risks of Hepatitis B reactivation in coinfected patients receiving treatment for Hepatitis C.
NOW PLAYING
Can DAA therapy for HCV reactivate HBV in coinfected patients?
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m